These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 25066368)
1. Intussusception following rotavirus vaccination: an updated review of the available evidence. Rha B; Tate JE; Weintraub E; Haber P; Yen C; Patel M; Cortese MM; DeStefano F; Parashar UD Expert Rev Vaccines; 2014 Nov; 13(11):1339-48. PubMed ID: 25066368 [TBL] [Abstract][Full Text] [Related]
2. Value of Post-Licensure Data on Benefits and Risks of Vaccination to Inform Vaccine Policy: The Example of Rotavirus Vaccines. Parashar UD; Cortese MM; Payne DC; Lopman B; Yen C; Tate JE Am J Prev Med; 2015 Dec; 49(6 Suppl 4):S377-82. PubMed ID: 26590437 [TBL] [Abstract][Full Text] [Related]
3. Intussusception and rotavirus vaccination: a review of the available evidence. Patel MM; Haber P; Baggs J; Zuber P; Bines JE; Parashar UD Expert Rev Vaccines; 2009 Nov; 8(11):1555-64. PubMed ID: 19863248 [TBL] [Abstract][Full Text] [Related]
4. Value of post-licensure data on benefits and risks of vaccination to inform vaccine policy: The example of rotavirus vaccines. Parashar UD; Cortese MM; Payne DC; Lopman B; Yen C; Tate JE Vaccine; 2015 Nov; 33 Suppl 4():D55-9. PubMed ID: 26122581 [TBL] [Abstract][Full Text] [Related]
5. Intussusception following rotavirus vaccine administration: post-marketing surveillance in the National Immunization Program in Australia. Buttery JP; Danchin MH; Lee KJ; Carlin JB; McIntyre PB; Elliott EJ; Booy R; Bines JE; Vaccine; 2011 Apr; 29(16):3061-6. PubMed ID: 21316503 [TBL] [Abstract][Full Text] [Related]
6. Postmarketing surveillance of intussusception following mass introduction of the attenuated human rotavirus vaccine in Mexico. Velázquez FR; Colindres RE; Grajales C; Hernández MT; Mercadillo MG; Torres FJ; Cervantes-Apolinar M; DeAntonio-Suarez R; Ortega-Barria E; Blum M; Breuer T; Verstraeten T Pediatr Infect Dis J; 2012 Jul; 31(7):736-44. PubMed ID: 22695189 [TBL] [Abstract][Full Text] [Related]
7. Risk of Intussusception After Rotavirus Vaccination: Meta-analysis of Postlicensure Studies. Rosillon D; Buyse H; Friedland LR; Ng SP; Velázquez FR; Breuer T Pediatr Infect Dis J; 2015 Jul; 34(7):763-8. PubMed ID: 26069948 [TBL] [Abstract][Full Text] [Related]
8. Postlicensure monitoring of intussusception after RotaTeq vaccination in the United States, February 1, 2006, to September 25, 2007. Haber P; Patel M; Izurieta HS; Baggs J; Gargiullo P; Weintraub E; Cortese M; Braun MM; Belongia EA; Miller E; Ball R; Iskander J; Parashar UD Pediatrics; 2008 Jun; 121(6):1206-12. PubMed ID: 18519491 [TBL] [Abstract][Full Text] [Related]
9. Intussusception after monovalent rotavirus vaccine-United States, Vaccine Adverse Event Reporting System (VAERS), 2008-2014. Haber P; Parashar UD; Haber M; DeStefano F Vaccine; 2015 Sep; 33(38):4873-7. PubMed ID: 26276687 [TBL] [Abstract][Full Text] [Related]
10. Review of Over 15 Years Postmarketing Safety Surveillance Spontaneous Data for the Human Rotavirus Vaccine (Rotarix) on Intussusception. Singh T; Delannois F; Haguinet F; Molo LY Drug Saf; 2022 Feb; 45(2):155-168. PubMed ID: 35015268 [TBL] [Abstract][Full Text] [Related]
11. Letter to the editor concerning the article 'Association between rotavirus vaccination and risk of intussusception among neonates and infants: a systematic review and meta-analysis' (JAMA Netw Open. 2019;2(10):e1912458). Benninghoff B; Pereira P; Willame C Hum Vaccin Immunother; 2020 Oct; 16(10):2502-2503. PubMed ID: 32186946 [TBL] [Abstract][Full Text] [Related]
12. Postmarketing monitoring of intussusception after RotaTeq vaccination--United States, February 1, 2006-February 15, 2007. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2007 Mar; 56(10):218-22. PubMed ID: 17363890 [TBL] [Abstract][Full Text] [Related]
13. Intussusception risk and disease prevention associated with rotavirus vaccines in Australia's National Immunization Program. Carlin JB; Macartney KK; Lee KJ; Quinn HE; Buttery J; Lopert R; Bines J; McIntyre PB Clin Infect Dis; 2013 Nov; 57(10):1427-34. PubMed ID: 23964090 [TBL] [Abstract][Full Text] [Related]
14. A benefit-risk analysis of rotavirus vaccination, France, 2015. Lamrani A; Tubert-Bitter P; Hill C; Escolano S Euro Surveill; 2017 Dec; 22(50):. PubMed ID: 29258644 [TBL] [Abstract][Full Text] [Related]
15. Rotavirus vaccination and intussusception - Science, surveillance, and safety: A review of evidence and recommendations for future research priorities in low and middle income countries. Yen C; Healy K; Tate JE; Parashar UD; Bines J; Neuzil K; Santosham M; Steele AD Hum Vaccin Immunother; 2016 Oct; 12(10):2580-2589. PubMed ID: 27322835 [TBL] [Abstract][Full Text] [Related]
16. Relationship between Pentavalent Rotavirus Vaccine and Intussusception: A Retrospective Study at a Single Center in Korea. Kim KY; Kim DS Yonsei Med J; 2017 May; 58(3):631-636. PubMed ID: 28332371 [TBL] [Abstract][Full Text] [Related]
18. Safety profile of rotavirus vaccines among individuals aged ≥8 months of age, United States, vaccine adverse event reporting system (VAERS), 2006-2019. Haber P; Tate J; Marquez PL; Moro PL; Parashar U Vaccine; 2021 Jan; 39(4):746-750. PubMed ID: 33267969 [TBL] [Abstract][Full Text] [Related]
19. Rotavirus vaccine and intussusception. Where do we go from here? Dennehy PH; Bresee JS Infect Dis Clin North Am; 2001 Mar; 15(1):189-207, x-xi. PubMed ID: 11301815 [TBL] [Abstract][Full Text] [Related]
20. European Society for Paediatric Infectious Diseases consensus recommendations for rotavirus vaccination in Europe: update 2014. Vesikari T; Van Damme P; Giaquinto C; Dagan R; Guarino A; Szajewska H; Usonis V Pediatr Infect Dis J; 2015 Jun; 34(6):635-43. PubMed ID: 25860532 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]